LXEO
LXEO
NASDAQ · Biotechnology

Lexeo Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.14
+0.06 (+1.47%)
As of Sep 22, 2:46 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,022.5% upside
Low Target $27.16
Average Target $46.47
High Target $57.70
Current Price $4.14
Current
$4.14
Target
$46.47
$27.16 $46.47 avg $57.70
Scenario Analysis
Bear Case
$27.16
556.0%
Low target
Base Case
$46.47
+1,022.5%
Avg target
Bull Case
$57.70
+1,293.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$10.99
-62.3% from high
52-Week Low
$3.99
+3.8% from low
Target vs 52W High
$46.47
+322.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%